About us
MorphoSys AG is a biopharmaceutical company, leading in the development of innovative therapeutic antibodies. With over 100 programs MorphoSys has one of the broadest antibody pipelines in the industry. The company develops proprietary antibodies, mainly for the treatment of inflammatory diseases and cancer, and works together with its partners to create antibodies against other indications, such as Alzheimer’s disease. The company was founded in 1992 and is headquartered in Martinsried, Germany. MorphoSys is listed on the Frankfurt Stock Exchange under the symbol MOR.
Logo_MOR_claim_RGB_word20140304-12627-3668a9
Loading...
No Records Found
Sorry, no records were found. Please adjust your search criteria and try again.
We use cookies to personalize content and ads, to provide social media features and to analyze our website traffic. We also share information about your use of our website with our social media, advertising, and analytics partners. Read more about how we use cookies by clicking on 'Privacy Policy'. Click the "I agree" button to continue to use this site.I agreePrivacy Policy
